Samuel Yousefzai

Samuel Yousefzai

Auto-generated profile, based on publicly available information

Samuel Yousefzai

Independent researcher, US

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2025 in Methodist DeBakey Cardiovascular Journal
Verified
Journal Article
Open access
PDF file
SYSamuel Yousefzai
Samuel Yousefzai
ZAZahir Amin
Zahir Amin
HFHuzaifa Faizan
Huzaifa Faizan
MAMaheen Ali
Maheen Ali
SSSuha Soni
Suha Soni
ZJZulqarnain Javed
Zulqarnain Javed
Perimenopause, or menopause transition (MT), is a critical life stage that encompasses significant physiological, emotional, and psychosocial changes that impact women’s cardiovascular health and quality of life. The decline in estrogen during MT induces adverse metabolic changes that increase the risk of dyslipidemia, obesity, insulin resistance, atherogenesis, and poor downstream outcomes such as diabetes, hypertension, stroke, and other adverse changes. Concurrently, stress plays an important role in shaping overall cardiovascular well-being during MT and long-term heart health post-menopause. In addition, nontraditional risk factors—particularly social determinants of health (SDoH) such as economic well-being, access to health care, built environment, social support, and others—are key upstream determinants of cardiovascular disease in women during perimenopause. Coordinated efforts are needed to screen, identify, and address the primary SDoH for optimal heart health in the clinically vulnerable MT patient population. Patient-centered care pathways that focus on assessing social needs and connecting socially vulnerable patients with available community resources are much needed for holistically addressing patient needs. Community-centered efforts are key to addressing persistent inequities in women’s cardiovascular health via navigation and connection to community resources that may help address SDoH barriers.

5 November 2024 in Methodist DeBakey Cardiovascular Journal
Verified
Journal Article
Open access
PDF file
RCRyan Chang
Ryan Chang
ZAZahir Amin
Zahir Amin
NCNuh Habibullah Cheema
Nuh Habibullah Cheema
SYSamuel Yousefzai
Samuel Yousefzai
KGKaram Gardezi
Karam Gardezi
ZJZulqarnain Javed
Zulqarnain Javed
Social determinants of health (SDOH) are known to determine a significant portion of a person’s health, influencing downstream outcomes and widespread disparities. Screening for SDOH in clinical practice can improve efficacy of medical care, highlighting the potential for polysocial risk scores (PsRS) to help evaluate a patient’s risk of developing atherosclerotic cardiovascular disease and other conditions. This review highlights existing research about the efficacy of PsRS in practical risk assessment, current gaps in the literature, and opportunities to refine the design and implementation of PsRS in real-world clinical settings. PsRS present unique opportunities to improve traditional risk prediction models for heart disease and other conditions, particularly if they examine both individual and area-level SDOH. Future studies should assess novel methods for extracting SDOH data from patients’ medical records as well as PsRS implementation strategies that promote efficiency and patient confidentiality in real-world clinical settings.